A plant genetics platform that activates endogenous GYPSY and COPIA transposon systems in tomato using gene editing to generate novel gene expression combinations and targeted gene knockouts. Demonstrated applications include breeding tomatoes with firmer texture and extended shelf life, and enhancing floral aroma compounds such as 2-phenylethanol.
This research program delivers a mutagenesis and trait-discovery platform for tomato built on activating dormant retrotransposon systems (GYPSY and COPIA) combined with targeted gene editing. By awakening these natural mobile genetic elements, the platform creates new allelic diversity and enables site-selected gene insertions or knockouts that are difficult to achieve through conventional breeding alone.
The approach has produced two validated proof-of-concept outcomes. First, a COPIA insertion in the xyloglucan endotransglucosylase/hydrolase gene slXTH9 produced a near-complete loss-of-function allele linked to firmer fruit texture and longer post-harvest shelf life. Second, a COPIA LTR-retrotransposon insertion in the intron of Solyc02g079490 generated a hypomorphic allele associated with elevated accumulation of 2-phenylethanol, a volatile responsible for the characteristic floral aroma of heirloom tomatoes.
The platform offers breeders, seed companies, and food industry partners a route to novel tomato varieties with improved post-harvest performance and enhanced sensory quality.
Core capabilities:
Key features:
The platform is at an early-to-mid technology readiness stage. Proof-of-concept has been established through published validation of two distinct trait applications: a loss-of-function slXTH9 allele for fruit firmness and a hypomorphic Solyc02g079490 allele for enhanced 2-phenylethanol accumulation. The next phase involves selecting target genes, constructing editing vectors, and performing genetic transformation, followed by in vitro expression checks in regenerants and progeny from seed. Further validation, including removal of the COPIA insertion through genome editing to formally confirm the role of Solyc02g079490, is planned.